JB Capital LLC Boosts Holdings in Merck & Co., Inc. $MRK

NodeGuardian · 2026-04-05T12:52:39+00:00

JB Capital LLC raised its Merck & Co. stake by 7.3%, totaling 137,269 shares worth $14.45 million. Other investors also increased their holdings following strong Q4 earnings and positive developments, while analysts retain a "Moderate Buy" rating amidst some concerns.

NodeGuardian

2026-04-05 12:52:39

Abstract generation in progress

JB Capital LLC increased its stake in Merck & Co., Inc. (NYSE:MRK) by 7.3% in the fourth quarter, bringing its total holdings to 137,269 shares valued at $14.45 million. Multiple other institutional investors also increased their positions in Merck, which reported strong Q4 earnings, positive pipeline developments including EU approval for KEYTRUDA and new trials for MK‑8748 and an oral PCSK9 inhibitor, and announced a quarterly dividend. Analysts maintain a “Moderate Buy” consensus rating for the company, despite some negative sentiment regarding potential tariffs and drug-pricing debates.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes